Is Globus Medical, Inc. (GMED) Overvalued?
We dive into why Globus Medical, Inc. (GMED) could be considered overvalued on 2026-07-23, based on AAII’s Value Score and Grade.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
Rosalio Madrigal
Michael Rose
| Share Statistics | GMED | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,695.3 | $337.2 | 78% |
|
| Shares Out (Mil) | 138.2 | 41.9 | 69% |
|
| Institutional Ownership | 82.6% | 77.8% | 51% |
|
| Float (Mil) | 111.7 | 34.7 | 63% |
|
| Beta | 1.00 | 0.85 | 60% |
|
| Avg Daily Volume (000s) | 1,240 | 278 | 75% |
|
| Price Change (52-week) |
47.4% | 58.7% | 79% |
|
| Growth | GMED | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 30.1% | 11.8% | 90% |
|
| Net Income (5yr) | 39.4% | (5.8%) | 90% |
|
| EPS (5yr) | 31.2% | 11.4% | 82 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (44.7%) | (16.3%) | 9% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 15 | 15 | 15 | |
| Current EPS | $1.099 | $4.740 | $5.145 | |
| Month Ago EPS | $1.098 | $4.743 | $5.145 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 0 | 2 | 1 | |
| Three Months Ago EPS | $1.060 | $4.472 | $4.950 | |
| Year/Year Chg | 22.1% | 20.9% | 44.8% | |
| Financials | GMED | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,101 | $152 | 67% |
|
| Net Income (TTM) (Mil) | $587 | ($10) | 81% |
|
| EPS (TTM) | $4.350 | ($0.500) | 85% |
|
| Operating Cash Flow (TTM) (Mil) | $779 | ($2) | 78% |
|
| Net Cash Flow (TTM) (Mil) | $100 | $1 | 77% |
|
| Long-Term Debt (Q1) (Mil) | $101 | $22 | 45% |
|
| Enterprise Value (Q1) (Mil) | $9,892 | $304 | 74% |
|
| Valuation | GMED | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.26 | 2.80 | 55% |
|
| P/E | 18.4 | 31.1 | 46% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.6 | 1.9 | 28% |
|
| Ratios | GMED | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 68.5% | 59.1% | 80% |
|
| Net Margin | 18.9% | (7.3%) | 78% |
|
| ROA | 11.6% | (13.7%) | 90% |
|
| ROE | 13.3% | (15.8%) | 67% |
|
| Liabilities to Assets | 13.0% | 44.7% | 8% |
|
| F-Score | 8 | 4 | 94% |
|
Globus Medical, Inc. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors